CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

How Machine Learning is Impacting Clinical Trials

How Machine Learning is Impacting...

Clasado Biosciences Joins Lucie Nagy as Head of Regulatory and Legal

Clasado Biosciences Joins Lucie Nagy...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

Major Challenges Facing Life Science and Pharmaceutical Supply Chains

Major Challenges Facing Life Science...

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

The Importance of Bioanalytical Method Validation

The Importance of Bioanalytical...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

How Machine Learning is Impacting Clinical Trials

How Machine Learning is Impacting...

Clasado Biosciences Joins Lucie Nagy as Head of Regulatory and Legal

Clasado Biosciences Joins Lucie Nagy...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

Major Challenges Facing Life Science and Pharmaceutical Supply Chains

Major Challenges Facing Life Science...

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

The Importance of Bioanalytical Method Validation

The Importance of Bioanalytical...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

Developing Trends in Biopharma Analysis

Life Sciences Review | Friday, August 13, 2021
Tweet

In addition to using peptide mapping concepts in Multi-Attribute Methods (MAMs), large biopharmaceutical firms are also using MS-based identity methods to unlock biologic medicines and drug materials.


FREMONT, CA: Efficient analytical methods are essential for the efficient production and commercialization of small and large molecule drug and consumer products. As the complexity of both biological and chemical drug compounds grows, analytical techniques must also change.


The most notable developments in analytical approaches include the use of Mass Spectrometry (MS) for process production and product release in both biologics and synthetic products. Additionally, they also comprise the enhancement of chromatographic techniques in specific Liquid Chromatography (LC), microcrystal electron diffraction, and methods for use as process analytical technology (PAT).


For biopharmaceuticals, MS was initially limited to the use of protein characterization to provide additional details for regulatory filings. Phase release/stability testing continues to be primarily based on traditional analytical methods like LC, Capillary Gel Electrophoresis (CGE), imaged Capillary Isoelectric Focusing (iCIEF), and Enzyme-Linked Immunosorbent Assays (ELISA) due to their simplicity and wide use in Quality Control (QC) laboratories. However, the incorporation of biosimilars, complex non-monoclonal antibody proteins (for example, fusion proteins), bispecific and hybrid drugs in the product pathway raises difficulties due to the failure to obtain a detailed understanding of these molecules through platform approaches.


Check Out: Top Pharma Logistics Solution Companies


In addition to using peptide mapping concepts in Multi-Attribute Methods (MAMs), large biopharmaceutical firms are also using MS-based identity methods to unlock biologic medicines and drug materials. MAM is a peptide mapping assay based on LC/MS. Unlike profile-based traditional analytical assays, which rely on whole or partial proteins, MAM can classify and measure protein modifications at the amino acids level. It can provide more detailed information on attributes relevant to product consistency.


MAM is perhaps the most critical new analytical technique used in the production and release, and stability testing of therapeutic proteins. In small-molecule drug production and commercialization, MS detection systems are no longer called simply analysis instruments. They are primarily used for routine QC monitoring, such as determining extremely low-level impurities such as genotoxic impurities/potential genotoxic impurities.


These developments are most likely a response to new regulatory recommendations provided by agencies, but often due to particular problems that have emerged in the market, such as recent questions about N-nitrosamine residual discoveries in sartans.


Weekly Brief

loading
Top 10 Bioanalytical Services Companies in Apac - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/developing-trends-in-biopharma-analysis-nwid-242.html